key: cord-0916093-3b4e53on authors: Bergamaschi, Luca; D’Angelo, Emanuela Concetta; Paolisso, Pasquale; Toniolo, Sebastiano; Fabrizio, Michele; Angeli, Francesco; Donati, Francesco; Magnani, Ilenia; Rinaldi, Andrea; Bartoli, Lorenzo; Chiti, Chiara; Biffi, Mauro; Pizzi, Carmine; Viale, Pierluigi; Galié, Nazzareno title: The value of ECG changes in risk stratification of COVID‐19 patients date: 2021-01-29 journal: Ann Noninvasive Electrocardiol DOI: 10.1111/anec.12815 sha: e51305176cd42caa236c86fa558aec0eacdca973 doc_id: 916093 cord_uid: 3b4e53on BACKGROUND: There is growing evidence of cardiac injury in COVID‐19. Our purpose was to assess the prognostic value of serial electrocardiograms in COVID‐19 patients. METHODS: We evaluated 269 consecutive patients admitted to our center with confirmed SARS‐CoV‐2 infection. ECGs available at admission and after 1 week from hospitalization were assessed. We evaluated the correlation between ECGs findings and major adverse events (MAE) as the composite of intra‐hospital all‐cause mortality or need for invasive mechanical ventilation. Abnormal ECGs were defined if primary ST‐T segment alterations, left ventricular hypertrophy, tachy or bradyarrhythmias and any new AV, bundle blocks or significant morphology alterations (e.g., new Q pathological waves) were present. RESULTS: Abnormal ECG at admission (106/216) and elevated baseline troponin values were more common in patients who developed MAE (p = .04 and p = .02, respectively). Concerning ECGs recorded after 7 days (159), abnormal findings were reported in 53.5% of patients and they were more frequent in those with MAE (p = .001). Among abnormal ECGs, ischemic alterations and left ventricular hypertrophy were significantly associated with a higher MAE rate. The multivariable analysis showed that the presence of abnormal ECG at 7 days of hospitalization was an independent predictor of MAE (HR 3.2; 95% CI 1.2–8.7; p = .02). Furthermore, patients with abnormal ECG at 7 days more often required transfer to the intensive care unit (p = .01) or renal replacement therapy (p = .04). CONCLUSIONS: Patients with COVID‐19 should receive ECG at admission but also during their hospital stay. Indeed, electrocardiographic alterations during hospitalization are associated with MAE and infection severity. Coronavirus disease 2019 (COVID-19) is a global pandemic, as World Health Organization (WHO) declared on March 11, 2020 (Mahase,2020) . SyndromeCoronavirus-2(SARS-CoV-2):thissingle-strandedenvel-opedRNAvirusinteractsthroughbindingofsurfacespikeprotein human angiotensin-converting enzyme 2 (ACE2) receptor. ACE2 is expressed in the lung and intestinal epithelium, vascular endothelium,kidneys,andheartaswell (Tikellis&Thomas,2012) .Theexact mechanism of cardiac involvement remains unclear. Probably, it is not onlyrelatedtotheinteractionbetweenproteinandreceptor.Other suggestedmechanismsofCOVID-19relatedtocardiacinvolvement includecytokinestormandhypoxiainducingexcessiveintracellular calcium leading to cardiac myocyte apoptosis (Zheng et al., 2020) . Troponin I or new ECG or echocardiographic abnormalities) was present in 7 to 1% of patients overall, and 26% required intensive care(Wangetal.,2020).ArecentstudyofShietal.comparing82 cardiacinjuryisassociatedwithahighriskofin-hospitalmortality (Shi et al., 2020) . ECG changes during viral infections were previously studied: ECG abnormalities during the 2009 H1N1 influenza infection were transient and not correlated with preexisting patient characteristics or with outcomes (Akritidis et al., 2010) . No spe-cificECGchangeshavebeendescribedinpatientswithSARS-CoV2 infection yet. The real prevalence of ECG anomalies and the inci-denceofbenignandmalignantarrhythmiasinCOVID-19infectionis stillnotwelldefined (Kochietal.,2020) . This study aims to investigate the relationship between abnor-malserialECGfindingsinpatientswithCOVID-19andmajoradverse events(MAE),consideredasthecompositeofall-causeintra-hospital mortality or respiratory failure requiring orotracheal intubation (OTI),todefinetheirprognosticvalue. Thestudyenrolled269consecutivepatientsadmittedtoSant'Orsola -Malpighi Hospital of Bologna University with laboratory-confirmed SARS-CoV-2infectionandradiologicalfindingssuggestiveofinter-stitialpneumoniafromMarch01,2020toApril10,2020 .Patients werefollowedupuntilApril20,2020 was established according to the WHO interim guidance and con-firmedbyRNAdetectionoftheSARS-CoV-2intheclinicallaboratory of Bologna Hospital . Chest radiographs or computedtomography(CT)scanswerealsodoneforallinpatients to assess lung parenchyma involvement. The exclusion criteria were age under 18 years old, lack of ECG at admission, and interstitial pneumoniawithoutmicrobiologicalconfirmationofSARS-CoV-2. Intra-hospital all-cause mortality, respiratory failure requiring orotrachealintubation,admissiontointensivecareunit(ICU),acute kidneyinjurytreatedwithrenalreplacementtherapy,andneedfor extracorporealmembraneoxygenation(ECMO)werecollected.We considered major adverse event (MAE) the composite of all-cause deathandrespiratoryfailurerequiringorotrachealintubationduring the hospitalization. Written informed consent was waived by the designated hospital's ethics committee for patients with emerging infectious diseases. All 12-lead electrocardiograms recorded on admission and 7 days later(paperspeedof25mm/sand1millivoltequivalentto10mm) wereanalyzedoff-line.Accordingtopre-definedcriteria,twoexpert cardiologists blinded to clinical information and non-invasive diagnosticresults,independentlyevaluatedtheECG.Athirdconsensus re-evaluationresolveddisagreementsinqualitativeevaluations. The considered parameters were as follows: rhythm (sinus, supraventricular or ventricular arrhythmias); heart rate; PR and QRS durations; QT and QTcorrected (using Bazett or Fridericia formula when the heart rate was >90beatsperminutewasused)intervals; conduction disturbances (atrioventricular block, bundle branch block,orfascicularblock)andST-Tsegmentalterations. The ST-segment deviation was measured as the height difference (inmillimeters)betweentheJpointandtheisoelectricline(TPsegment).Twavewasanalyzedinall12leadsandclassifiedasnormal (positiveinallleadsapartfromIII, aVR, V1, withvoltage≥0.1mV), inverted(negativeinanyleadexceptIII, aVR, V1, withvoltage≥0.1mV) orflat(voltage<0.1mV).PathologicalQwaveswereidentifiedasany Q wave >40 ms wide, >2 mm deep or >25%ofQRScomplexdepth. According to the ESC guidelines (Ibanez et al., 2018; Roffi et al., 2016) , ST-T segment alterations were classified as primary if suggesting acute ischemia. Left ventricular hypertrophy (LVH) was definedusingSokolow-Lyoncriteria(SinV1+RinV5orV6≥35mm orRinaVL≥11mm)withorwithoutsecondaryST-Tsegmentchanges. Electrocardiogram was defined as abnormal for any patient if ischemia alterations, left ventricular hypertrophy, tachy or bradyarrhythmias,andanynewatrioventricular(AV),bundlebranchblocks, or significant morphology alterations (e.g., new Q pathological waves)werepresent.Otherwise,patientspresentingsinusrhythm without previously described alterations were reported as normal. cardiacinjury,COVID-19,electrocardiogram,outcomes,riskstratification We collected cardiac biomarkers, troponin I (Tn I), creatine kinase (CK), and brain natriuretic peptide (BNP). Troponin I levels were defined as elevated if they were above the "high-sensitive" assayspecificupperreferencelimit(cut-offof11.6ng/Lforwomenand 19.8ng/Lformen).Demographiccharacteristics(ageandsex),clinicaldata(symptoms,comorbidities,laboratoryfindings)andtherapy were collected from electronic medical records. Severe COVID-19 wasdefinedasmeetingarterialoxygensaturation≤93%atrestor PaO 2 /FiO 2 ≤300 mm Hg. We did not include respiratory rate ≥30 breaths/min according to the Diagnosis and Treatment Plan of COVID-19suggestedbyNationalHealthCommissionofChinadue totheconsiderableinter-observervariability(Yangetal.,2020). InTable4,wereportedbaselineandclinicalfindingsin74patients withnormalECGcomparedto85patientswithabnormalECGevalu-atedat7-dayECG. AccordingtotherecentliteratureonCOVID-19,severerespiratory distress was independently associated with the need for intensive careandintra-hospitalmortality(Yangetal.,2020).Newperspectives enlightened that SARS-CoV-2 infection is associated with cardiac injury resulting from a direct or indirect effect on cardiovascular system, as described in other coronavirus strains (Inciardi etal.,2020; Shietal.,2020) .ECGisausefultoolineverydaypractice to recognize myocardial damage due to the widespread availability. Interestingly, abnormal changes at 12-lead electrocardiogram did not reflect the population's baseline clinical characteristics but were directly associated with the severity of COVID-19. In fact, there were no differences in clinical history, hemodynamic state, main laboratory parameters, and medical treatments whether patients had Sellers et al., 2017) . Beyond oxygen supply-demand mismatch, another cause could be the direct protein-receptor interaction. The spike protein of SARS-CoV-2 has a strong binding affinity to angiotensin-converting enzyme 2 (ACE2) receptor, which is also highly expressed in the heart and in the lung parenchyma (Tikellis &Thomas,2012) . Another putative mechanism is the cytokine storm syndrome with an uncontrolled dysfunctional immune response, leading directly to apoptosis or necrosis of myocardial cells (de Jong et al., 2006; Ruan et al., 2020; Wong et al., 2004) . In response to the infection, the acute increase of different circulating pro-inflammatorycytokines(includingIL-6,IL-1,TNF-α,andinterferon)iscor-relateddirectlywithanunfavorableprognosisinCOVID-19 (Ragab et al., 2020) . The cytokine storm can also trigger a prothrombotic andantifibrinolyticimbalancethatfavorsthrombusformation (Libby & Lüscher, 2020) . Therefore, antithrombotic therapy with heparin canimprovetheprognosisofthesepatients(Paolissoetal.,2020). Finally, inflammatory mediators may also trigger arrhythmias (e.g., atrial fibrillation and/or ventricular arrhythmias), especially in the Ourstudyhassomelimitations.First,thisstudywasconductedin a single medical center with a relatively small number of patients. Nevertheless,ourinstitutionistheregionalcoordinatingcenterfor theCOVID-19inourregion. Furthermore, in our study, some clinical or laboratory data at baseline and during follow-up are missing due to practical difficulty in managing clinical reports because of a serious infectious problem. Finally, due to various logistical issues, only 30 echocardiograms wereperformed,andthesedatawerenotanalyzed.Indeed,itcould be useful to perform an echocardiographic evaluation in each patient with suspected myocardial damage. These findings suggest that in patients with COVID-19, it is a good practice to collect a basal ECG and repeat the 12 lead ECG evaluation during the hospitalization stay due to the high burden of information related. None. None. Written informed consent was waived by the ethics committee of the designated hospital for patients with emerging infectious diseases. The data that support the findings of this study are available from thecorrespondingauthoruponreasonablerequest. Luca Bergamaschi https://orcid.org/0000-0001-8186-9717 Mauro Biffi https://orcid.org/0000-0003-4590-8584 Carmine Pizzi https://orcid.org/0000-0002-4048-675X Electrocardiographic Abnormalities in Patients With Novel H1N1 InfluenzaVirusInfection Inpatientuseof ambulatorytelemetrymonitorsforCOVID-19patientstreatedwith hydroxychloroquine and/or azithromycin Fataloutcomeofhumaninfluenza A (H5N1) is associated with high viral load and hypercytokinemia Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes Hydroxychloroquineandazithromy-cinasatreatmentofCOVID-19:Resultsofanopen-labelnon-randomized clinical trial 2017ESCGuidelinesforthemanagementofacutemyo-cardial infarction in patients presenting with ST-segment elevation Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) Cardiac and arrhythmic complications in patients with COVID-19 COVID-19 is, in the end, an endothelial disease Effectofhighinfluenzaactivityonriskofventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction Negativeim-pactofhyperglycemiaonTocilizumabtherapyinCOVID-19patients Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) Preliminaryexperiencewithlow molecularweightheparinstrategyinCOVID-19patients TheCOVID-19CytokineStorm 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Clinical pre-dictorsofmortalityduetoCOVID-19basedonananalysisofdata of 150 patients from Wuhan, China TheEffectofchloroquine,hydroxychloroquineandazith-romycinonthecorrectedQTintervalinpatientswithSARS-CoV-2 infection The hiddenburdenofinfluenza:Areviewoftheextra-pulmonarycomplications of influenza infection. Influenza and Other Respiratory Viruses Associationof cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan RecognizingCOVID-19-relatedmyocarditis:Thepossiblepathophysiologyandproposed guideline for diagnosis and management Angiotensin-converting enzyme 2 (ACE2)isakeymodulatorofthereninangiotensinsysteminhealth and disease Clinicalcharacteristicsof138hospitalizedpatientswith2019novel coronavirus-infected pneumonia in Wuhan Plasmainflammatorycytokinesandchemokinesinsevere acute respiratory syndrome Clinical course and outcomes of critically ill patients with SARS-CoV-2pneumoniainWuhan,China:Asingle-centered,retrospective, observational study. The Lancet COVID-19andthe cardiovascular system ThevalueofECGchangesinrisk stratificationofCOVID-19patients